Skip to content

Red flags and safety concerns

TL;DR — Almost everything sight-threatening after cataract surgery declares itself in the first week, and the two conditions that must be separated urgently are infectious endophthalmitis and toxic anterior segment syndrome (TASS). TASS starts 12–48 hours after surgery, is confined to the anterior segment, is always Gram-stain and culture negative, and improves with steroid; endophthalmitis is typically later, more painful, involves the vitreous, and requires immediate intravitreal antibiotics (Mamalis 2006, PMID 16565012). Because bacterial identification is now possible after antibiotic administration, injection should not be delayed for culture, and intravitreal antibiotics should not be routinely repeated at 48 hours — vitrectomy should be considered instead if the picture is not improving (Clarke 2018, PMID 29453989). A third syndrome deserves separate recognition: vancomycin-associated haemorrhagic occlusive retinal vasculitis (HORV), in which the day-1 undilated examination is unremarkable and painless vision loss follows 1–21 days later, with poor visual outcomes in most of 36 reported eyes (Witkin 2017, PMID 28110950). Outside the perioperative window, the recurring safety issues are unvalidated "cataract-dissolving" eye drops with no reliable evidence of benefit (Dubois 2017, PMID 28245346) and expectation mismatch after premium-lens implantation (Pusnik 2022, PMID 36676002).

Postoperative emergencies

Presentation Likely diagnosis Time course Action
Pain, decreasing vision, hypopyon, vitritis Acute infectious endophthalmitis Typically days 1–7, occasionally later Immediate intravitreal antibiotics; vitreous sample but do not delay injection (PMID 29453989)
Diffuse limbus-to-limbus corneal oedema, anterior chamber reaction, usually painless, no vitreous involvement Toxic anterior segment syndrome 12–48 hours Intensive topical steroid; Gram stain and culture will be negative; investigate the whole operative environment (PMID 16565012)
Painless vision loss, unremarkable day-1 undilated exam, mild AC and vitreous inflammation, sectoral retinal haemorrhage in ischaemic areas, venule predilection Vancomycin-associated HORV 1–21 days after surgery or injection Recognise, stop intraocular vancomycin, urgent retinal referral; outcomes usually poor (PMID 28110950)
Severe pain, corneal oedema, very high IOP Early postoperative IOP spike Peak at 3–4 hours postoperatively IOP-lowering therapy; risk factors include retained viscoelastic, glaucoma, pseudoexfoliation, axial length >25 mm, tamsulosin, steroid response (Grzybowski 2019, PMID 30489361)
New floaters, flashes, curtain in the visual field Rhegmatogenous retinal detachment Weeks to years Urgent dilated examination; pooled incidence 0.66 per 100 patients, higher in men (OR 1.73) and long eyes (Alshammari 2024, PMID 39172224)
Gradual blur, glare, contrast loss months to years later Posterior capsule opacification — but confirm Months to years Nd:YAG capsulotomy after excluding macular disease, IOL opacification and capsular contraction (Gaonker 2023, PMID 35245234)

Endophthalmitis: recognition and treatment

The treatment framework still rests on the Endophthalmitis Vitrectomy Study, which established that all patients with postoperative endophthalmitis should receive direct intravitreal antibiotic injection and randomised the roles of initial vitrectomy and intravenous antibiotics (Doft 1991, PMID 2012545). A 2022 Cochrane review found no eligible completed modern randomised trial (Muqit 2022, PMID 36398614), but that absence is now stale: a later 57-eye randomised trial in post-cataract endophthalmitis presenting with acuity from hand movements to <6/18 found similar final mean acuity with immediate vitrectomy and tap-and-inject (0.14 vs 0.22 logMAR, p = 0.2), greater letter gain with vitrectomy (66.36 vs 43.36, p = 0.02), and non-significantly fewer reinterventions (8% vs 39%, p = 0.09) (Sen 2023, PMID 36791396). A meta-analysis of seven non-randomised comparative studies (188 eyes) instead found better final acuity with initial tap-and-inject (weighted mean difference −0.61 logMAR, 95% CI −1.19 to −0.03, p = 0.04, I² = 89%, GRADE very low), with similar enucleation and retinal-detachment risks (Mihalache 2024, PMID 36803934). The small trial and confounded observational synthesis point in different directions, so selection by presenting severity remains unresolved.

Practical points from the review literature: vitreous culture remains the diagnostic gold standard, but modern identification methods work after antibiotics have been given, so injection should be immediate; current intravitreal regimens are comprehensive and need no change; and repeat intravitreal antibiotics at 48 hours are not recommended, with vitrectomy considered instead if the eye is not improving (PMID 29453989). Older reviews of antibiotic therapy in postoperative endophthalmitis provide the pharmacological background (Wang 2002, PMID 12759845; Hanscom 2004, PMID 14765348). Prevention is covered in complications and anaesthesia and perioperative care.

Risk factors that should raise suspicion: absence of intracameral antibiotic prophylaxis (4.92-fold risk), clear-corneal rather than scleral-tunnel incision (5.88-fold), silicone IOL optic (3.13-fold), and any intraoperative surgical complication (4.95-fold) (ESCRS Endophthalmitis Study Group 2007, PMID 17531690). Posterior capsule rupture raises endophthalmitis risk more than six-fold, which is why intracameral prophylaxis in that subgroup lowers incidence (OR 0.41, 95% CI 0.26–0.65) (Arteche 2026, PMID 40958158); in EUREQUO, endophthalmitis occurred in 0.11% after PCR versus 0.02% without (aOR 4.40, 2.48–7.81) (Segers 2022, PMID 35179858).

Toxic anterior segment syndrome

TASS is a sterile inflammatory reaction caused by a non-infectious substance entering the anterior segment. Its diagnostic signature is the combination of onset at 12–48 hours, confinement to the anterior segment, consistently negative Gram stain and culture, and steroid responsiveness (PMID 16565012). Reported causes include intraocular solutions of inappropriate composition, concentration, pH or osmolality; preservatives; denatured ophthalmic viscosurgical devices; enzymatic detergents; bacterial endotoxin; oxidised metal deposits and residues; and IOL polishing or sterilising residues (PMID 16565012). An outbreak is therefore a sterile-processing and supply-chain investigation, not a clinical one: a multistate US outbreak investigation demonstrates the required approach (Kutty 2008, PMID 18361979), and later reviews and outbreak reports confirm the pattern, including a viscoelastic-triggered cluster and paediatric cases (Park 2018, PMID 30359246; Altıntaş 2017, PMID 28546691; Centers for Disease Control and Prevention 2007, PMID 17597694; Arı 2012, PMID 21939434; Sengillo 2020, PMID 33313293).

Haemorrhagic occlusive retinal vasculitis

HORV is the reason vancomycin is no longer a routine intracameral choice despite ranking highest in observational prophylaxis networks. In a joint ASCRS/ASRS task-force case series, 36 eyes of 23 patients met predetermined diagnostic criteria; all had received intraocular vancomycin (intracameral bolus in 33, intravitreal injection in 1, irrigation bottle in 2), and presentation occurred 1 to 21 days after surgery or injection. The characteristic sequence is an unremarkable undilated day-1 examination, delayed painless vision loss, mild anterior chamber and vitreous inflammation, and sectoral retinal haemorrhage in ischaemic areas with a predilection for venules and the periphery; visual outcomes were usually poor (PMID 28110950). The practical consequence is that vancomycin usage has collapsed — to 6% of surveyed American surgeons by 2021, against moxifloxacin at 83% (Lieu 2024, PMID 37877364) — and that a delayed painless vision loss after apparently uneventful surgery must not be dismissed as "expected variation" (Grzybowski 2021, PMID 32343980; Haripriya 2018, PMID 29095716).

Intraocular pressure

Early postoperative IOP elevation may account for up to 88% of early postoperative complications. Risk factors are residual viscoelastic material, resident-performed surgery, glaucoma, pseudoexfoliation, axial length over 25 mm, tamsulosin use and steroid responsiveness. Peak IOP occurs 3–4 hours after surgery — before a day-1 review would detect it — and no agent completely prevents spikes; a topical dorzolamide/timolol plus brinzolamide combination is recommended for high-risk eyes with pre-existing optic nerve damage, and corticosteroid cessation usually normalises steroid-induced elevation (PMID 30489361; Katz 2024, PMID 39503401). This is one reason NICE recommends against routine in-person day-1 review after uncomplicated surgery while requiring processes for prompt access when complications are suspected — see guidelines.

Process safety: wrong lens and wrong eye

Wrong-lens implantation is treated as a never event in the English system, with a prescribed prevention protocol: identity confirmation before biometry; no hand transcription of biometry results; electronic transfer or secure attachment of printed results; recording of the discussed refractive outcome; a WHO-based checklist confirming identity, marked eye, a single matching lens in theatre with identical and alternative lenses in stock, and two team members including the surgeon having checked formulas, calculations and constants; and root-cause analysis when it happens (NICE — "Cataracts in adults: management" NG77, recommendations 1.5.1–1.5.8, https://www.nice.org.uk/guidance/ng77, accessed 2026-08-31). Broader perioperative adverse-event prevention is discussed in (Rabinowitz 2018, PMID 30059403).

Preoperative safety flags

Flag Why it matters Source
α1-antagonist exposure (current or prior, either sex) Intraoperative floppy iris syndrome in ~2% of operations, with higher complication risk; antipsychotics and hypertension also implicated Enright 2017, PMID 27653607
Pseudoexfoliation with poor mydriasis, shallow chamber, lens decentration Zonular complications; OR up to 287.39 with all three features Hayashi 2024, PMID 38290806
Axial length >26 mm Only 63% achieve ≥20/40; higher refractive surprise, IOP spike, capsular contraction and detachment risk Elhusseiny 2023, PMID 36473016
Previous vitrectomy Higher dropped-nucleus, PCO and CME risk; worse acuity and prediction error Lundström 2020, PMID 32649433; Lundström 2020, PMID 32126043
Diabetic retinopathy Higher PCR risk (OR 2.74) and postoperative retinopathy progression Segers 2022, PMID 34074994; Loya 2025, PMID 39956206
Dense/white cataract Higher PCR (OR 1.87) and dropped nucleus; NICE advises explaining the risk of delay PMID 34074994; PMID 32126043
Single functional eye NICE requires close supervision of trainees in cases where complications would be especially severe NICE NG77 recommendation 1.3.12, accessed 2026-08-31

Medication and drop safety

Drug-induced cataract is under-recognised. Disproportionality analysis of 54,800 FAERS reports identified 24 drugs with significant cataract signals, led by difluprednate (BCPNN 7.83, median onset 74 days), prednisolone (6.84, 141 days) and erdafitinib (5.44), with glucocorticoids, insulin analogues, nitisinone and ranibizumab prominent and antineoplastic agents showing the longest average onset (533.89 days) (Hong 2025, PMID 40707607). Corticosteroid risk is route- and duration-graded, from skin preparations (RR 1.43) to oral use beyond five years (3.25, 95% CI 1.39–7.58) (Prokofyeva 2013, PMID 22715900). Postoperative drop burden itself carries risks of instillation error and ocular-surface toxicity, which is the rationale for drop-free intracameral and periocular delivery (Shorstein 2020, PMID 31688226), and for shortening prophylaxis where evidence permits (Aragona 2021, PMID 33081522).

Unvalidated "cataract-dissolving" products

Products marketed directly to consumers as reversing or dissolving cataract are not supported by the randomised evidence. N-acetylcarnosine — the only such agent with a Cochrane assessment — has no reliable evidence of benefit (PMID 28245346), while its supporting literature is concentrated in reviews authored by the formulation's proponents (Babizhayev 2016, PMID 26084629; Babizhayev 2014, PMID 24783234). More broadly, the randomised test of the antioxidant hypothesis was negative in 4,757 AREDS participants (AREDS Research Group 2001, PMID 11594943), and no agent has ever been shown to clear an established human cataract (Zhao 2015, PMID 26200341; de Diego-García 2025, PMID 40565122). The safety concern is delay: a person using drops instead of seeking assessment accumulates avoidable disability, and in some settings a denser cataract carries higher surgical risk.

Health information online is of uneven quality. The 100 most-viewed cataract videos on one short-video platform were scored on four validated instruments and quality varied substantially by uploader group (Cao 2025, PMID 40755956) — a reason to direct patients to verified organisation material (patient experience and advocacy).

Expectation mismatch as a safety issue

Dissatisfaction after technically uncomplicated surgery is common enough to belong here. Positive dysphotopsia affects up to 67% of patients immediately, persists at one year in 2.2%, and prompts surgery in 0.07%; negative dysphotopsia affects up to 26% early and 0.13–3% at one year (PMID 36676002; Hu 2018, PMID 29084005). Refractive surprise is the other driver, with a randomised-trial benchmark of only 71% of eyes within ±0.5 D (Day 2020, PMID 32386810), and management options of differing predictability (Alio 2015, PMID 25321444). Because the framing of risk demonstrably changes how patients perceive it — median risk-perception score 2 with positive framing versus 3 with negative framing (p < 0.0001) — pre-operative counselling is itself a safety intervention (Martinez 2024, PMID 38729627).

Open questions

  • Tap-and-inject or vitrectomy? The foundational randomised evidence is three decades old (PMID 2012545), but a 57-eye modern trial found similar final mean acuity with greater letter gain after immediate vitrectomy (PMID 36791396), while the seven-study observational meta-analysis favours tap-and-inject at GRADE very low certainty (PMID 36803934).
  • Can HORV be predicted? All 36 reported eyes had received intraocular vancomycin, but the incidence denominator is unknown and no host or dose predictor has been identified (PMID 28110950).
  • What is the optimal postoperative review schedule? IOP peaks at 3–4 hours (PMID 30489361), NICE recommends against routine day-1 review, and a 291-patient randomised trial found no disadvantage to omitting it after uneventful surgery (PMID 22738668); rare sight-threatening outcomes remain beyond that trial's power.
  • How large is the harm from unvalidated drops? No reliable benefit exists (PMID 28245346), but no study quantifies delayed presentation or worse surgical outcomes attributable to their use.
  • Does structured risk framing improve decisions? Framing changes perception (PMID 38729627), but no study links a framing intervention to decision quality, regret or outcome.

References

  1. Mamalis N, Edelhauser HF, Dawson DG, et al. Toxic anterior segment syndrome. Journal of cataract and refractive surgery. 2006;32:324-33. PMID 16565012
  2. Clarke B, Williamson TH, Gini G, et al. Management of bacterial postoperative endophthalmitis and the role of vitrectomy. Survey of ophthalmology. 2018;63:677-693. PMID 29453989
  3. Witkin AJ, Chang DF, Jumper JM, et al. Vancomycin-Associated Hemorrhagic Occlusive Retinal Vasculitis: Clinical Characteristics of 36 Eyes. Ophthalmology. 2017;124:583-595. PMID 28110950
  4. Dubois VD, Bastawrous A. N-acetylcarnosine (NAC) drops for age-related cataract. The Cochrane database of systematic reviews. 2017;2:CD009493. PMID 28245346
  5. Pusnik A, Petrovski G, Lumi X. Dysphotopsias or Unwanted Visual Phenomena after Cataract Surgery. Life (Basel, Switzerland). 2022;13. PMID 36676002
  6. Grzybowski A, Kanclerz P. Early postoperative intraocular pressure elevation following cataract surgery. Current opinion in ophthalmology. 2019;30:56-62. PMID 30489361
  7. Alshammari AJ, Alqam RA, Aldeej MA, et al. Retinal Detachment Following Cataract Surgery: A Systematic Review and Meta-analysis of Incidence, Preoperative Risk Factors, and Postoperative Complications. Ophthalmic surgery, lasers & imaging retina. 2024;55:668-674. PMID 39172224
  8. Gaonker T, Yadav A, Nishad A. Post-Cataract Surgery Decreased Vision-Is It Always Posterior Capsule Opacification?. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.). 2023;12:107. PMID 35245234
  9. Doft BH. The endophthalmitis vitrectomy study. Archives of ophthalmology (Chicago, Ill. : 1960). 1991;109:487-9. PMID 2012545
  10. Muqit MM, Mehat M, Bunce C, et al. Early vitrectomy for exogenous endophthalmitis following surgery. The Cochrane database of systematic reviews. 2022;11:CD013760. PMID 36398614
  11. Mihalache A, Patil NS, Popovic MM, et al. Tap and inject of intravitreal antibiotics versus pars plana vitrectomy for post-cataract surgery endophthalmitis: a meta-analysis. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2024;59:73-78. PMID 36803934
  12. Wang RC, Lou PL, Ryan EA, et al. Antibiotic therapy in post-operative endophthalmitis. Seminars in ophthalmology. 2002;17:153-61. PMID 12759845
  13. Hanscom TA. Postoperative endophthalmitis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2004;38:542-6. PMID 14765348
  14. Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. Journal of cataract and refractive surgery. 2007;33:978-88. PMID 17531690
  15. Arteche MAT, Hira S, Melo Dos Anjos Filho V, et al. Use of intracameral antibiotics prophylaxis in patients with posterior capsular rupture during cataract surgery: systematic review and meta-analysis. Journal of cataract and refractive surgery. 2026;52:303-309. PMID 40958158
  16. Segers MHM, Behndig A, van den Biggelaar FJHM, et al. Outcomes of cataract surgery complicated by posterior capsule rupture in the European Registry of Quality Outcomes for Cataract and Refractive Surgery. Journal of cataract and refractive surgery. 2022;48:942-946. PMID 35179858
  17. Kutty PK, Forster TS, Wood-Koob C, et al. Multistate outbreak of toxic anterior segment syndrome, 2005. Journal of cataract and refractive surgery. 2008;34:585-90. PMID 18361979
  18. Park CY, Lee JK, Chuck RS. Toxic anterior segment syndrome-an updated review. BMC ophthalmology. 2018;18:276. PMID 30359246
  19. Altıntaş AK, Ciritoğlu MY, BeyazyıldıZ Ö, et al. Toxic Anterior Segment Syndrome Outbreak after Cataract Surgery Triggered by Viscoelastic Substance. Middle East African journal of ophthalmology. 2017;24:43-47. PMID 28546691
  20. Centers for Disease Control and Prevention (CDC). Toxic anterior segment syndrome after cataract surgery--Maine, 2006. MMWR. Morbidity and mortality weekly report. 2007;56:629-30. PMID 17597694
  21. Ari S, Caca I, Sahin A, et al. Toxic anterior segment syndrome subsequent to pediatric cataract surgery. Cutaneous and ocular toxicology. 2012;31:53-7. PMID 21939434
  22. Sengillo JD, Chen Y, Perez Garcia D, et al. Postoperative Endophthalmitis and Toxic Anterior Segment Syndrome Prophylaxis: 2020 Update. Annals of translational medicine. 2020;8:1548. PMID 33313293
  23. Lieu AC, Jun JH, Afshari NA. Intracameral antibiotics during cataract surgery: efficacy, safety, and cost-benefit considerations. Current opinion in ophthalmology. 2024;35:50-56. PMID 37877364
  24. Grzybowski A, Brona P, Zeman L, et al. Commonly used intracameral antibiotics for endophthalmitis prophylaxis: A literature review. Survey of ophthalmology. 2021;66:98-108. PMID 32343980
  25. Haripriya A, Chang DF. Intracameral antibiotics during cataract surgery: evidence and barriers. Current opinion in ophthalmology. 2018;29:33-39. PMID 29095716
  26. Katz EA, Majmudar S, Aref AA. Prophylaxis and treatment of acute intraocular pressure rise after cataract surgery: considerations to aid in decision-making. Expert review of clinical pharmacology. 2024;17:995-997. PMID 39503401
  27. Rabinowitz LE, Lamper L, Tendler JM, et al. Preventing Adverse Events in Cataract Surgery. Anesthesia and analgesia. 2018;127:e66. PMID 30059403
  28. Enright JM, Karacal H, Tsai LM. Floppy iris syndrome and cataract surgery. Current opinion in ophthalmology. 2017;28:29-34. PMID 27653607
  29. Hayashi K, Yoshida M, Manabe SI, et al. High-risk factors for zonular complications during cataract surgery in eyes with pseudoexfoliation syndrome. The British journal of ophthalmology. 2024;108:1193-1199. PMID 38290806
  30. Elhusseiny AM, Salim S. Cataract surgery in myopic eyes. Current opinion in ophthalmology. 2023;34:64-70. PMID 36473016
  31. Lundström M, Dickman M, Henry Y, et al. Cataract surgery of eyes with previous vitrectomy: risks and benefits as reflected in the European Registry of Quality Outcomes for Cataract and Refractive Surgery. Journal of cataract and refractive surgery. 2020;46:1402-1407. PMID 32649433
  32. Lundström M, Dickman M, Henry Y, et al. Risk factors for dropped nucleus in cataract surgery as reflected by the European Registry of Quality Outcomes for Cataract and Refractive Surgery. Journal of cataract and refractive surgery. 2020;46:287-292. PMID 32126043
  33. Segers MHM, Behndig A, van den Biggelaar FJHM, et al. Risk factors for posterior capsule rupture in cataract surgery as reflected in the European Registry of Quality Outcomes for Cataract and Refractive Surgery. Journal of cataract and refractive surgery. 2022;48:51-55. PMID 34074994
  34. Loya A, Hussain ZS, Muayad J, et al. Risk of Progression of Nonproliferative to Proliferative Diabetic Retinopathy after Cataract Surgery. Ophthalmology. 2025;132:817-822. PMID 39956206
  35. Hong SY, Lu WR, Chen XD, et al. Pharmacovigilance of drug-induced cataract using the FDA Adverse Event Reporting System. Scientific reports. 2025;15:26921. PMID 40707607
  36. Prokofyeva E, Wegener A, Zrenner E. Cataract prevalence and prevention in Europe: a literature review. Acta ophthalmologica. 2013;91:395-405. PMID 22715900
  37. Shorstein NH, Myers WG. Drop-free approaches for cataract surgery. Current opinion in ophthalmology. 2020;31:67-73. PMID 31688226
  38. Aragona P, Postorino EI, Aragona E. Post-surgical management of cataract: Light and dark in the 2020s. European journal of ophthalmology. 2021;31:287-290. PMID 33081522
  39. Babizhayev MA, Yegorov YE. Telomere Attrition in Human Lens Epithelial Cells Associated with Oxidative Stress Provide a New Therapeutic Target for the Treatment, Dissolving and Prevention of Cataract with N-Acetylcarnosine Lubricant Eye Drops. Kinetic, Pharmacological and Activity-Dependent Separation of Therapeutic Targeting: Transcorneal Penetration and Delivery of L-Carnosine in the Aqueous Humor and Hormone-Like Hypothalamic Antiaging Effects of the Instilled Ophthalmic Drug Through a Safe Eye Medication Technique. Recent patents on drug delivery & formulation. 2016;10:82-129. PMID 26084629
  40. Babizhayev MA, Yegorov YE. Biomarkers of oxidative stress and cataract. Novel drug delivery therapeutic strategies targeting telomere reduction and the expression of telomerase activity in the lens epithelial cells with N-acetylcarnosine lubricant eye drops: anti-cataract which helps to prevent and treat cataracts in the eyes of dogs and other animals. Current drug delivery. 2014;11:24-61. PMID 24783234
  41. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Archives of ophthalmology (Chicago, Ill. : 1960). 2001;119:1439-52. PMID 11594943
  42. Zhao L, Chen XJ, Zhu J, et al. Lanosterol reverses protein aggregation in cataracts. Nature. 2015;523:607-11. PMID 26200341
  43. de Diego-García L, Rejas-González R, Latre IC, et al. Pharmacological Strategies for Cataract Management: From Molecular Targets to Clinical Translation. International journal of molecular sciences. 2025;26. PMID 40565122
  44. Cao J, Zhang F, Zhu Z, et al. Quality of cataract-related videos on TikTok and its influencing factors: A cross-sectional study. Digital health. 2025;11:20552076251365086. PMID 40755956
  45. Hu J, Sella R, Afshari NA. Dysphotopsia: a multifaceted optic phenomenon. Current opinion in ophthalmology. 2018;29:61-68. PMID 29084005
  46. Day AC, Burr JM, Bennett K, et al. Femtosecond Laser-Assisted Cataract Surgery Versus Phacoemulsification Cataract Surgery (FACT): A Randomized Noninferiority Trial. Ophthalmology. 2020;127:1012-1019. PMID 32386810
  47. Alio JL, Abdelghany AA, Fernández-Buenaga R. Enhancements after cataract surgery. Current opinion in ophthalmology. 2015;26:50-5. PMID 25321444
  48. Martinez DL, Ahmed IIK, Schlenker MB. Risk communication in cataract surgery. BMJ open ophthalmology. 2024;9. PMID 38729627
  49. Sen AC, Mehta SM, Sule A, et al. IMMEDIATE VITRECTOMY vs TAP AND INJECT IN EYES WITH ACUTE POSTCATARACT ENDOPHTHALMITIS AND VISUAL ACUITY ≥HM: A Randomized Clinical Trial. Retina (Philadelphia, Pa.). 2023;43:940-946. PMID 36791396
  50. Chatziralli IP, Sergentanis TN, Kanonidou E, et al. First postoperative day review after uneventful phacoemulsification cataract surgery: is it necessary? BMC research notes. 2012;5:333. PMID 22738668